Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician.
about
Suppression of alcohol dependence using baclofen: a 2-year observational study of 100 patientsNovel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulationGABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidencePharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey.The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study.Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.An Unusual Case of Baclofen AbuseMulti-center trial of baclofen for abstinence initiation in severe cocaine-dependent individualsReducing effect of the positive allosteric modulator of the GABA(B) receptor, GS39,783, on alcohol self-administration in alcohol-preferring rats.Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates.A human laboratory pilot study with baclofen in alcoholic individualsAddiction and brain reward and antireward pathways.Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.Liquid chromatography high resolution mass spectrometry for the determination of baclofen and its metabolites in plasma: Application to therapeutic drug monitoring.Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Baclofen in the management of inhalant withdrawal: a case series.Baclofen: a new drug for the treatment of alcohol dependence.Phenotypic characterization of genetically selected Sardinian alcohol-preferring (sP) and -non-preferring (sNP) rats.Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint?Clinical effectiveness of baclofen for the treatment of alcohol dependence: a reviewAcute interaction of baclofen in combination with alcohol in heavy social drinkersEffect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats.Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence.Efficacy and tolerability of baclofen in substance use disorders: a systematic review.Current pharmacological treatment approaches for alcohol dependence.Alcohol modulation of G-protein-gated inwardly rectifying potassium channels: from binding to therapeutics.Molecular basis of alcoholism.Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment.Characteristics of Patients with Alcohol Dependence Seeking Baclofen Treatment in France: A Two-Centre Comparative Cohort Study.Neuromodulation Therapies for Alcohol Addiction: A Literature Review.Clinical experience of baclofen in alcohol dependence: A chart review.Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.Self-poisoning with baclofen in alcohol-dependent patients: national reports to French Poison Control Centers, 2008-2013.Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety.Baclofen Abuse due to Its Hypomanic Effect in Patients with Alcohol Dependence and Comorbid Major Depressive Disorder.Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers.
P2860
Q21129114-A2EE74E2-1573-4BE1-894E-FB317653D808Q26853630-76D4C33B-02C7-4FDF-90A6-A26F4038E326Q27026530-DBAF42B8-EF05-4F53-9108-C2F4B57C60CFQ33582063-D2DB14E2-BE0D-4A54-A084-EAD13DFBFDAAQ33699486-28768A5B-A719-4EFF-8E32-6072C03FEAD3Q33757216-53FF2AE1-9E6D-4D39-B34A-8BAE8DE52004Q34246904-DD73327C-B317-4695-8C82-6EA1D0A64D39Q34277168-DF431EC5-9B34-4787-8764-79ECDB060553Q34544427-ABBA8DE1-A253-4227-9C5B-E25A9F76324EQ34607261-BF888871-2532-465E-87E5-3B40EFCD5669Q34613495-8BD3DC2D-3C7C-40C1-95B6-BE9D18530769Q34642726-89C203FB-CB0B-46E6-A31A-9F08E76D4326Q34871492-F7878B37-F8D4-45D1-96DD-1A4F7F48290AQ35995170-20DF0433-C13F-46B2-AFAD-BAC973AEACE8Q36095127-C5592360-2464-459D-8C29-C115C46701F3Q36231851-F66A4437-5958-44EF-984A-42C2AC499EDFQ36249705-5EB27FA8-EF98-4E7E-9A13-1564CB8A4E22Q36372867-EEE6CEDC-8433-41CC-A8F6-69C36C5BA130Q36474092-C9DE4343-AB56-4456-B828-D582A91A609BQ36558764-7F663233-FEA7-49FA-9400-83E3CFDEB0DFQ36589464-90DE6728-DDA5-48BD-BEF5-37D98A2CC2EEQ36900876-AFE0A34A-275E-462E-B5C2-DD659E7EB4E2Q36996573-524CF0D9-E30F-4001-8DF0-1F7D360C1404Q37060525-62337A74-AA24-4B8D-B6F2-CA737EFB838FQ37705299-AF52C192-CAF6-4331-8519-D4166743E215Q37965229-509BFFD2-7381-4BDC-B12D-E3321030CE21Q38115144-6AE19B66-9A99-4C8E-A0A9-E5396373E2C8Q38181213-1EFB4583-3B65-45EC-B6FC-E85AFC21F7F0Q38194551-B89A6D71-D11F-46B7-AC27-822C3C31835AQ38259368-125D7DD4-2132-4CE0-A14E-03C5D11D06E1Q38697044-B9D69402-FBCC-4284-B09E-EC1628E39606Q38778760-1AAEC649-AA01-4723-B286-63EC134997A4Q38804127-ECEB231F-C7FE-492B-9C25-C81E16834E28Q39068253-29A1425F-CE13-4C88-8508-C4510E4D3C04Q39120782-F97C826B-D078-40A9-8A82-6BE80A335624Q39144955-846E0D1E-5EC0-4FE1-A4AC-4834BF1A5C0AQ40353606-7BD1ABC6-3BCF-4BD0-8F78-10298205CA4AQ40462255-E1428234-3C68-4C60-908D-F2607E8C841DQ42352465-2DAE8E6D-D676-490F-BB37-D6253DFBEF5AQ42640821-53C5FA71-2851-4BA8-A054-BCFAF21EDB7A
P2860
Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Complete and prolonged suppres ...... lf-case report of a physician.
@ast
Complete and prolonged suppres ...... lf-case report of a physician.
@en
type
label
Complete and prolonged suppres ...... lf-case report of a physician.
@ast
Complete and prolonged suppres ...... lf-case report of a physician.
@en
prefLabel
Complete and prolonged suppres ...... lf-case report of a physician.
@ast
Complete and prolonged suppres ...... lf-case report of a physician.
@en
P2860
P356
P1476
Complete and prolonged suppres ...... lf-case report of a physician.
@en
P2093
Olivier Ameisen
P2860
P304
P356
10.1093/ALCALC/AGH130
P577
2004-12-13T00:00:00Z